Neurology Medical News about pituitary adenomas

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications
Endocrine-Related Cancer, 08/28/09

Jaffrain–Rea ML et al. – The authors conclude that down–regulation of AIP and AHR may be involved in the aggressiveness of somatotrophinomas. Overall, IHC is a poorly sensitive tool for the screening of AIP mutations. Data obtained on AHR expression suggest that AHR signalling may be differentially affected according to PA phenotype.

<< Previous
Automated Optimization of Subcortical Cerebral MR Imaging–Atlas...

Next >>
Expression of excision repair cross complementing group 1 and...

Signalling Pathway Alterations in Pituitary Adenomas: Involvement of Gsalpha, cAMP and Mitogen-Activated Protein Kinases
Journal of Neuroendocrinology, 11/03/09 Relevance Score: 68%

Regulation of Pituitary Function by Cytokines
Hormone Research, 10/27/09 Relevance Score: 67%

Apoplexy in non functioning pituitary adenoma after one dose of leuprolide as treatment for prostate cancer
Pituitary, 10/29/09 Relevance Score: 66%

Pituitary metastasis of Merkel cell carcinoma
Journal of Neuro-Oncology, 10/28/09 Relevance Score: 66%

Predicting Recurrence of Nonfunctioning Pituitary Adenomas
Journal of Clinical Endocrinology and Metabolism, 10/15/09 Relevance Score: 66%